Patients with increased CD4+ and CD8+ T-cells also showed a trend towards improved outcome in a study by Imaizumi et al.
← all excerpts
Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review.
1
—
—